Biodefense Industry Share: Key Players & Regional Investments

The 21st century has ushered in a new era of biological threats not only from naturally emerging diseases but also from engineered pathogens, bioterrorism, and laboratory accidents. The biodefense market, once narrowly focused on vaccines and protective equipment, has evolved into a complex, technology driven ecosystem encompassing genomics, surveillance, bioinformatics, and artificial intelligence. Artificial Intelligence (AI) now stands at the forefront of Biodefense transformation. It enables early detection, real time monitoring, and predictive response to biological threats with a speed and accuracy that were previously unattainable. Between 2025 and 2035, the global biodefense market is expected to undergo rapid expansion, driven by growing security concerns, national preparedness programs, and AI driven innovation in biotechnology.
read more..